Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Mast Cell Activation Disorders × Imatinib Mesylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Gastrointestinal Stromal Tumors 2 Progressive Gastrointestinal Stromal Tumor 1 Myeloproliferative Disorders 1 Mastocytosis, Systemic 1 Mastocytosis 1 Mast Cell Activation Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Hematologic Neoplasms 1 Blast Crisis 1

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 4 Completed

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡